The CeRA is a Center of Excellence for research and clinical service in andrology and reproduction. Its research is dedicated to solve important questions in basic reproductive functions and clinical applications, providing benefits for patients at the earliest opportunity. Scientists and physicians combine their multi-disciplinary expertise in reproductive medicine/biology and molecular reproductive physiology. Additional expertise from physics, chemistry, gynecology, human genetics and stem cell research are added to elucidate the basic principles of fertilization. Moreover, translational and clinical studies are performed to develop novel treatments for human fertility disorders, the control and maintenance of reproductive functions, and the generation of cells and gametes for therapeutic procedures. CeRA consists of the Institute of Reproductive and Regenerative Biology, the Department of Clinical Andrology, and the Assisted Reproduction unit.
Centrum für Reproduktionsmedizin und Andrologie11. Münsteraner Andrologie-Update 2019 der Abt. für Klinische und Operative Andologie
Centrum für Reproduktionsmedizin und Andrologie11. Münsteraner Andrologie-Update 2019
The CeRA originates from the fusion of the Department of Experimental Endocrinology of the University Womans Hospital and the local Clinical Research Unit “Reproductive Medicine” of the Max-Planck Society, funded from 1976 until 1980. In 1987, the CeRA was assigned a WHO Collaborative Center for the elucidation of the male reproductive function and, since 1994, serves as a Training Center for Clinical Andrologists of the European Academy of Andrology (EAA). Moreover, the CeRA has been certified (1999-present) by the TÜV Rheinland (DIN EN ISO 9001:2008) for the field of “Patient Care and Clinical Research in Reproductive Medicine, Andrology, Endocrinology, and Urology”. It is home to the QuaDeGA program (Quality control of the German Society of Andrology) and offers courses in semen analysis for medical technical assistants; the CeRA also initiated and organizes a Europe-wide quality-control program concerning the detection of micro deletions of the Y chromosome.